1-4 of 4
Sujun Gao, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Wei Xu, MD PhD, Yongping Song, Zengjun Li, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Jianfeng Zhou, Sujun Gao, PhD, Kaiyang Ding, Huilai Zhang, MD, Zunmin Zhu, MD, Shunqing Wang, Bing Xu, Jianda Hu, PhD, Ting Liu, MD, Chunyan Ji, Zhongjun Xia, MD, Yan Li, PhDMD, Xin Wang, MD PhD, Zhixin Xu, Renbin Zhao, Bin Zhang, PhD, Alan Zhu, Jianyong Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4319.
https://doi.org/10.1182/blood-2019-123331
Published: 2019
Journal Articles

Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study

Lixin Wang, PhD MD, Guofeng Chen, MD, Jianliang Shen, MD PhD, Jianmin Luo, Meiyun Fang, MD, Xudong Wei, MD, Yinghua Li, MD, Zhuogang Liu, MD, Yin Zhang, MD, Sujun Gao, PhD, Xin Wang, MD PhD, Xiaoning Gao, MD PhD, Wei Zhou, MD, Yigai Ma, MD, Hui Liu, MD, Xinquan Li, MD PhD, Linhua Yang, MD, Li Yu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2707.
https://doi.org/10.1182/blood-2018-99-111761
Published: 2018
Journal Articles

Prospective Cohort Study Comparing Intravenous Busulfan Versus Total Body Irradiation in Cord Blood Transplantation

Baolin Tang, Xiaoyu Zhu, Changcheng Zheng, Huilan Liu, Siguo Hao, MD PhD, Dongping Huang, Dongjun Lin, Nainong LI, Sujun Gao, PhD, Xinquan Liang, Jianjun Li, Lulu Huang, Liangquan Geng, Kaiyang Ding, Xingbing Wang, MD, Wen Yao, Kaidi Song, Xuhan Zhang, Xiang Wan, Lei Zhang, Juan Tong, Guangyu Sun, Zimin Sun
Journal: Blood
Blood (2018) 132 (Supplement 1): 5709.
https://doi.org/10.1182/blood-2018-99-118681
Published: 2018
Journal Articles

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

Yuqin Song, MD PhD, Keshu Zhou, MD, Dehui Zou, MD, Jianfeng Zhou, PhD, Jianda Hu, PhD, Haiyan Yang, PhD, Huilai Zhang, PhD, Jie Ji, MD, Wei Xu, MD PhD, Jie Jin, MD PhD, Fangfang Lv, MD, Ru Feng, MD, Sujun Gao, PhD, Daobin Zhou, MD, Haiyi Guo, MD, Aihua Wang, PhD, James Hilger, PhD, Jane Huang, MD, William Novotny, MD, Muhtar Osman, PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 148.
https://doi.org/10.1182/blood-2018-99-117956
Published: 2018